Stockreport

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

Pluri Inc.  (PLUR) 
PDF Pluri’s patent enables mass-scale production of immune cell therapiesNew patented technology is applicable for the expansion of a variety of immune cellsTechnology sets [Read more]